Abraxis develops, manufactures, and markets rapid environmental, food, and life sciences test systems, including immunochemistry products and methods, to meet the testing needs of research and ...
Antibodies, Kits, etc
Revolutionizing cancer therapy on a global basis by developing TCR therapies with the potential to treat a wide range of cancer types and patients.
T Cell and B Cell receptor analysis with Clonoseq.
ADMA Biologics is a biopharmaceutical company committed to creating superior products for immunodeficient patients at risk for infection.
Aduro’s three proprietary technology platforms (Live, Attenuated Double-Deleted Listeria (LADD), STING Pathway Activators, and B-select monoclonal antibodies) have the potential to transform the ...
Advaxis’ Lm Technology uses live, attenuated bioengineered Listeria monocytogenes (Lm) bacteria to stimulate the immune system to view tumor cells as potentially ...
Equipment and antibodies for immunoassays
Agenus uses the power of the immune system to develop innovative product candidates against cancer. The company has assembled a broad portfolio of antibodies including checkpoint inhibitors and ...
Alder BioPharmaceuticals is developing monoclonal antibody therapeutics for the treatment of migraine, Cushing’s disease, Congenital Adrenal Hyperplasia and autoimmune and inflammatory diseases.
Developing therapeutics that harness the brain’s immune system to treat neurodegeneration such as Alzheimer's.
Biologics. Amgen makes several therapeutic drugs that target serious disease. Many are derived from engineered monoclonal antibodies. Some target immune receptors.
Aminex Therapeutics, Inc., is a drug development company focused on discovery and development of a unique cancer drug therapy in the general category of cancer immunotherapies known as checkpoint ...
Uses modified antibodies to generate immunotherapeutics.